E-selectin is a viable route of infection for polymer-coated adenovirus retargeting in TNF-α-activated human umbilical vein endothelial cells

References

• Alon R, Feizi T, Yuen CT, Fuhlbrigge RC, Springer TA. (1995). Glycolipid ligands for selectins support leukocyte tethering and rolling under physiologic flow conditions. J Immunol, 154, 5356–5366.
   PubMed Web of Science ®Google Scholar
• Asgeirsdóttir SA, Kok RJ, Everts M, Meijer DK, Molema G. (2003). Delivery of pharmacologically active dexamethasone into activated endothelial cells by dexamethasone-anti-E-selectin immunoconjugate. Biochem Pharmacol, 65, 1729–1739.
   PubMed Web of Science ®Google Scholar
• Barthel SR, Gavino JD, Descheny L, Dimitroff CJ. (2007). Targeting selectins and selectin ligands in inflammation and cancer. Expert Opin Ther Targets, 11, 1473–1491.
   PubMed Web of Science ®Google Scholar
• Bergelson JM. (1999). Receptors mediating adenovirus attachment and internalization. Biochem Pharmacol, 57, 975–979.
   Google Scholar
• Bergelson JM, Cunningham JA, Droguett G, Kurt-Jones EA, Krithivas A, Hong JS, Horwitz MS, Crowell RL, Finberg RW. (1997). Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science, 275, 1320–1323.
   PubMed Web of Science ®Google Scholar
• Bevilacqua MP, Pober JS, Mendrick DL, Cotran RS, Gimbrone MA Jr. (1987). Identification of an inducible endothelial-leukocyte adhesion molecule. Proc Natl Acad Sci USA, 84, 9238–9242.
   PubMed Web of Science ®Google Scholar
• Bhaskar V, Law DA, Ibsen E, Breinberg D, Cass KM, DuBridge RB, Evangelista F, Henshall SM, Hevezi P, Miller JC, Pong M, Powers R, Senter P, Stockett D, Sutherland RL, von Freeden-Jeffry U, Willhite D, Murray R, Afar DE, Ramakrishnan V. (2003). E-selectin up-regulation allows for targeted drug delivery in prostate cancer. Cancer Res, 63, 6387–6394.
   PubMed Web of Science ®Google Scholar
• Brenner W, Hempel G, Steinbach F, Hohenfellner R, Thüroff JW. (1999). Enhanced expression of ELAM-1 on endothelium of renal cell carcinoma compared to the corresponding normal renal tissue. Cancer Lett, 143, 15–21.
   PubMed Web of Science ®Google Scholar
• Carlisle RC, Di Y, Cerny AM, Sonnen AF, Sim RB, Green NK, Subr V, Ulbrich K, Gilbert RJ, Fisher KD, Finberg RW, Seymour LW. (2009). Human erythrocytes bind and inactivate type 5 adenovirus by presenting Coxsackie virus-adenovirus receptor and complement receptor 1. Blood, 113, 1909–1918.
   PubMed Web of Science ®Google Scholar
• Defilippi P, Truffa G, Stefanuto G, Altruda F, Silengo L, Tarone G. (1991). Tumor necrosis factor alpha and interferon gamma modulate the expression of the vitronectin receptor (integrin beta 3) in human endothelial cells. J Biol Chem, 266, 7638–7645.
   PubMed Web of Science ®Google Scholar
• Denekamp J. (1990). Vascular attack as a therapeutic strategy for cancer. Cancer Metastasis Rev, 9, 267–282.
   PubMed Web of Science ®Google Scholar
• Dimitroff CJ, Lee JY, Rafii S, Fuhlbrigge RC, Sackstein R. (2001). CD44 is a major E-selectin ligand on human hematopoietic progenitor cells. J Cell Biol, 153, 1277–1286.
   PubMed Web of Science ®Google Scholar
• Fisher KD, Stallwood Y, Green NK, Ulbrich K, Mautner V, Seymour LW. (2001). Polymer-coated adenovirus permits efficient retargeting and evades neutralising antibodies. Gene Ther, 8, 341–348.
   PubMed Web of Science ®Google Scholar
• Fuhlbrigge RC, Kieffer JD, Armerding D, Kupper TS. (1997). Cutaneous lymphocyte antigen is a specialized form of PSGL-1 expressed on skin-homing T cells. Nature, 389, 978–981.
   PubMed Web of Science ®Google Scholar
• Fuhlbrigge RC, King SL, Sackstein R, Kupper TS. (2006). CD43 is a ligand for E-selectin on CLA+ human T cells. Blood, 107, 1421–1426.
   PubMed Web of Science ®Google Scholar
• Funovics M, Montet X, Reynolds F, Weissleder R, Josephson L. (2005). Nanoparticles for the optical imaging of tumor E-selectin. Neoplasia, 7, 904–911.
   PubMed Web of Science ®Google Scholar
• Gout S, Morin C, Houle F, Huot J. (2006). Death receptor-3, a new E-Selectin counter-receptor that confers migration and survival advantages to colon carcinoma cells by triggering p38 and ERK MAPK activation. Cancer Res, 66, 9117–9124.
   PubMed Web of Science ®Google Scholar
• Green NK, Herbert CW, Hale SJ, Hale AB, Mautner V, Harkins R, Hermiston T, Ulbrich K, Fisher KD, Seymour LW. (2004). Extended plasma circulation time and decreased toxicity of polymer-coated adenovirus. Gene Ther, 11, 1256–1263.
   PubMed Web of Science ®Google Scholar
• Howitt J, Anderson CW, Freimuth P. (2003). Adenovirus interaction with its cellular receptor CAR. Curr Top Microbiol Immunol, 272, 331–364.
   PubMed Web of Science ®Google Scholar
• Kansas GS. (1996). Selectins and their ligands: current concepts and controversies. Blood, 88, 3259–3287.
   PubMed Web of Science ®Google Scholar
• Keelan ET, Licence ST, Peters AM, Binns RM, Haskard DO. (1994). Characterization of E-selectin expression in vivo with use of a radiolabeled monoclonal antibody. Am J Physiol, 266, H278–H290.
   PubMedGoogle Scholar
• Kotovuori P, Tontti E, Pigott R, Shepherd M, Kiso M, Hasegawa A, Renkonen R, Nortamo P, Altieri DC, Gahmberg CG. (1993). The vascular E-selectin binds to the leukocyte integrins CD11/CD18. Glycobiology, 3, 131–136.
   PubMed Web of Science ®Google Scholar
• Kuzmin AI, Finegold MJ, Eisensmith RC. (1997). Macrophage depletion increases the safety, efficacy and persistence of adenovirus-mediated gene transfer in vivo. Gene Ther, 4, 309–316.
   PubMed Web of Science ®Google Scholar
• Leeuwenberg JF, Smeets EF, Neefjes JJ, Shaffer MA, Cinek T, Jeunhomme TM, Ahern TJ, Buurman WA. (1992). E-selectin and intercellular adhesion molecule-1 are released by activated human endothelial cells in vitro. Immunology, 77, 543–549.
   PubMed Web of Science ®Google Scholar
• McEver RP, Martin MN. (1984). A monoclonal antibody to a membrane glycoprotein binds only to activated platelets. J Biol Chem, 259, 9799–9804.
   PubMed Web of Science ®Google Scholar
• Montgomery KF, Osborn L, Hession C, Tizard R, Goff D, Vassallo C, Tarr PI, Bomsztyk K, Lobb R, Harlan JM. (1991). Activation of endothelial-leukocyte adhesion molecule 1 (ELAM-1) gene transcription. Proc Natl Acad Sci USA, 88, 6523–6527.
   PubMed Web of Science ®Google Scholar
• Moore KL. (1998). Structure and function of P-selectin glycoprotein ligand-1. Leuk Lymphoma, 29, 1–15.
   PubMed Web of Science ®Google Scholar
• Morrison J, Briggs SS, Green NK, Thoma C, Fisher KD, Kehoe S, Seymour LW. (2009). Cetuximab retargeting of adenovirus via the epidermal growth factor receptor for treatment of intraperitoneal ovarian cancer. Hum Gene Ther, 20, 239–251.
   PubMed Web of Science ®Google Scholar
• Murakami P, McCaman MT. (1999). Quantitation of adenovirus DNA and virus particles with the PicoGreen fluorescent Dye. Anal Biochem, 274, 283–288.
   PubMed Web of Science ®Google Scholar
• Ogawara K, Rots MG, Kok RJ, Moorlag HE, Van Loenen AM, Meijer DK, Haisma HJ, Molema G. (2004). A novel strategy to modify adenovirus tropism and enhance transgene delivery to activated vascular endothelial cells in vitro and in vivo. Hum Gene Ther, 15, 433–443.
   PubMed Web of Science ®Google Scholar
• Oupicky D, Ogris M, Howard KA, Dash PR, Ulbrich K, Seymour LW. (2002). Importance of lateral and steric stabilization of polyelectrolyte gene delivery vectors for extended systemic circulation. Mol Ther, 5, 463–472.
   PubMed Web of Science ®Google Scholar
• Picker LJ, Warnock RA, Burns AR, Doerschuk CM, Berg EL, Butcher EC. (1991). The neutrophil selectin LECAM-1 presents carbohydrate ligands to the vascular selectins ELAM-1 and GMP-140. Cell, 66, 921–933.
   PubMed Web of Science ®Google Scholar
• Pigott R, Dillon LP, Hemingway IH, Gearing AJ. (1992). Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cells. Biochem Biophys Res Commun, 187, 584–589.
   PubMed Web of Science ®Google Scholar
• Ritter T, Brandt C, Prösch S, Vergopoulos A, Vogt K, Kolls J, Volk HD. (2000). Stimulatory and inhibitory action of cytokines on the regulation of hCMV-IE promoter activity in human endothelial cells. Cytokine, 12, 1163–1170.
   PubMed Web of Science ®Google Scholar
• Ruoslahti E. (2002). Specialization of tumour vasculature. Nat Rev Cancer, 2, 83–90.
   PubMed Web of Science ®Google Scholar
• Sallusto F, Lenig D, Förster R, Lipp M, Lanzavecchia A. (1999). Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature, 401, 708–712.
   PubMed Web of Science ®Google Scholar
• Schellerer VS, Croner RS, Weinländer K, Hohenberger W, Stürzl M, Naschberger E. (2007). Endothelial cells of human colorectal cancer and healthy colon reveal phenotypic differences in culture. Lab Invest, 87, 1159–1170.
   Google Scholar
• Sedlacek HH. (2001). Pharmacological aspects of targeting cancer gene therapy to endothelial cells. Crit Rev Oncol Hematol, 37, 169–215.
   PubMed Web of Science ®Google Scholar
• Sprague AH, Khalil RA. (2009). Inflammatory cytokines in vascular dysfunction and vascular disease. Biochem Pharmacol, 78, 539–552.
   PubMed Web of Science ®Google Scholar
• Steegmaier M, Levinovitz A, Isenmann S, Borges E, Lenter M, Kocher HP, Kleuser B, Vestweber D. (1995). The E-selectin-ligand ESL-1 is a variant of a receptor for fibroblast growth factor. Nature, 373, 615–620.
   PubMed Web of Science ®Google Scholar
• Stevenson M, Hale AB, Hale SJ, Green NK, Black G, Fisher KD, Ulbrich K, Fabra A, Seymour LW. (2007). Incorporation of a laminin-derived peptide (SIKVAV) on polymer-modified adenovirus permits tumor-specific targeting via alpha6-integrins. Cancer Gene Ther, 14, 335–345.
   PubMed Web of Science ®Google Scholar
• Šubr V, Ulbrich K. (2006). Synthesis and properties of new N-(2-hydroxypropyl)-methacrylamide copolymers containing thiazolidine-2-thione reactive groups. React Func Pol, 66, 1525–1538.
   Web of Science ®Google Scholar
• Subramaniam M, Koedam JA, Wagner DD. (1993). Divergent fates of P- and E-selectins after their expression on the plasma membrane. Mol Biol Cell, 4, 791–801.
   PubMed Web of Science ®Google Scholar
• Tan PH, Manunta M, Ardjomand N, Xue SA, Larkin DF, Haskard DO, Taylor KM, George AJ. (2003). Antibody targeted gene transfer to endothelium. J Gene Med, 5, 311–323.
   PubMed Web of Science ®Google Scholar
• Thorp KM, Southern C, Bird IN, Matthews N. (1992). Tumour necrosis factor induction of ELAM-1 and ICAM-1 on human umbilical vein endothelial cells–analysis of tumour necrosis factor-receptor interactions. Cytokine, 4, 313–319.
   PubMed Web of Science ®Google Scholar
• Vincent T, Pettersson RF, Crystal RG, Leopold PL. (2004). Cytokine-mediated downregulation of coxsackievirus-adenovirus receptor in endothelial cells. J Virol, 78, 8047–8058.
   PubMed Web of Science ®Google Scholar
• von Asmuth EJ, Smeets EF, Ginsel LA, Onderwater JJ, Leeuwenberg JF, Buurman WA. (1992). Evidence for endocytosis of E-selectin in human endothelial cells. Eur J Immunol, 22, 2519–2526.
   PubMed Web of Science ®Google Scholar
• Waddington SN, McVey JH, Bhella D, Parker AL, Barker K, Atoda H, Pink R, Buckley SM, Greig JA, Denby L, Custers J, Morita T, Francischetti IM, Monteiro RQ, Barouch DH, van Rooijen N, Napoli C, Havenga MJ, Nicklin SA, Baker AH. (2008). Adenovirus serotype 5 hexon mediates liver gene transfer. Cell, 132, 397–409.
   PubMed Web of Science ®Google Scholar
• Wickham TJ, Mathias P, Cheresh DA, Nemerow GR. (1993). Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment. Cell, 73, 309–319.
   PubMed Web of Science ®Google Scholar
• Wolff G, Worgall S, van Rooijen N, Song WR, Harvey BG, Crystal RG. (1997). Enhancement of in vivo adenovirus-mediated gene transfer and expression by prior depletion of tissue macrophages in the target organ. J Virol, 71, 624–629.
   PubMed Web of Science ®Google Scholar